Genomics

Dataset Information

Biopsy analysis of trial S1616: Ipilimumab plus nivolumab versus ipilimumab alone in patients with anti-PD-1-refractory melanoma


ABSTRACT: Biopsy analysis of trial S1616: Ipilimumab plus nivolumab versus ipilimumab alone in patients with anti-PD-1-refractory melanoma

PROVIDER: PRJNA1263048 | ENA |

REPOSITORIES: ENA